Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs iShares 7-10 Year Treasury Bond ETF (IEF) Price & Performance

ARK Genomic Revolution ETF
iShares 7-10 Year Treasury Bond ETF

Price performance

Price movement over the last 24 hours

Key statistics

ARK Genomic Revolution ETF vs iShares 7-10 Year Treasury Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while iShares 7-10 Year Treasury Bond ETF trades at $93.63. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.

ARKGIEF
Sector
Sector/Thematic
52-Week High
$43.57$97.99
52-Week Low
$23.09$93.11

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Genomic Revolution ETF

ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.

The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.

iShares 7-10 Year Treasury Bond ETF

IEF trades at $93.63, down 0.09% on the day, with a bearish technical signal driven by moving averages. Recent news highlights bond market volatility amid shifting Fed rate expectations, with inflows into bond ETFs surging 60% year-over-year as of June 25, 2026 (CNBC). Dividend payments remain consistent, with the latest H1-26 payout at $0.32.

Outlook is cautious due to interest rate uncertainty; the Fed's potential hikes pose a headwind, but elevated demand for Treasury ETFs may provide support. Key risks include inflation persistence and geopolitical tensions impacting oil prices, as noted in Reuters and New York Post coverage on July 8, 2026.

Returns comparison

Trailing returns across standard periods

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About iShares 7-10 Year Treasury Bond ETF

The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.

Read more on IEF